Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual
about
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers ProgramDeterminants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.The strategic case for establishing public-private partnerships in cancer careTrends in Consent for Clinical Trials in Cardiovascular Disease.Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the CommunityRacial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment.Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.Clinical trial insurance coverage for cancer patients under the Affordable Care Act.
P2860
Q33816617-64486382-86B5-4D7F-A299-935B3D7987D3Q35572502-D20EE778-F25D-4852-AD7D-AEE014AA70BCQ35917852-661E0D85-3EC4-4FF3-94C6-D4DF84F43053Q36159229-8982FE81-53C8-493F-AE33-99B984523E08Q37076220-93516B40-D9A1-405F-AC8B-0279828A699FQ37157666-DB19ED52-D62E-490C-8279-6698AC151B97Q37626917-98CB075C-952A-4E77-A2F6-5B69DB270EA1Q37739370-EABE97FA-35F5-4FDF-9157-8B7B7EA7AE50Q38740914-F71ECB1E-96F8-44F4-BD62-E1FBE0E96A0BQ40215022-14ADD728-821F-409D-AEF2-192C6EFE99DDQ47556957-F88F80D3-C24F-4F37-AC2D-715E5D62297AQ55002577-D9AEFECC-BFA9-443B-97ED-F82DC144E799
P2860
Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of the National Cancer Ins ...... cancer clinical trial accrual
@en
Use of the National Cancer Ins ...... cancer clinical trial accrual.
@nl
type
label
Use of the National Cancer Ins ...... cancer clinical trial accrual
@en
Use of the National Cancer Ins ...... cancer clinical trial accrual.
@nl
prefLabel
Use of the National Cancer Ins ...... cancer clinical trial accrual
@en
Use of the National Cancer Ins ...... cancer clinical trial accrual.
@nl
P2093
P2860
P356
P1476
Use of the National Cancer Ins ...... cancer clinical trial accrual
@en
P2093
Andrea M Denicoff
Angela Carrigan
Brenda Duggan
Diane St Germain
Donna M Bryant
Eileen P Dimond
Kathy Wilkinson
Maria M Gonzalez
Michael A Thompson
Rebecca A Enos
P2860
P304
P356
10.1200/JOP.2013.001194
P407
P577
2014-01-14T00:00:00Z